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Abstract 
Study Design. A comparative study of radiation dose measured in anthropomorphic phantoms.  
Objectives.First, to report the first organ dose and effective dose measurements in 
anthropomorphic phantoms using the new EOS imaging micro-dose protocol in full-spine 
examinations.Next, to compare these measurements of radiation dose to measurements in the 
EOS standard-dose protocol and CR. 
Summary of Background Data.Few studies evaluating organ dose and effective dose for the 
EOS low-dose scanner exists, and mainly for the standard-dose protocol. To the best of our 
knowledge, no studies of effective dose based on anthropomorphic phantom measurements exits 
for the new micro-dose protocol. 
Methods.Two anthropomorphic phantoms, representing a 5-year-old (pediatric) and a 15-year-
old (adolescent). The phantoms were exposed to EOS micro-dose and standard-dose protocols 
during full-spine imaging. Additionally, CR in scoliosis settings was performed. For all 
modalities, organ doses were measured and effective doses were calculated using 
thermoluminescent dosimeters (TLD).  
Results.We found a 17-fold reduction (94%) of effective dose in micro-dose protocol compared 
with our CR system in the adolescent phantom. Micro-dose versus standard-dose protocol, 
showed a 6-fold reduction (83%), and for standard-dose versus our CR system a 2.8-fold 
reduction (64%) reduction of effective dose was observed.   
For the pediatric phantom, a 5-fold reduction (81%) of effective dose in micro-dose protocol 
compared to our CR system was observed. Micro-dose versus standard-dose protocol, showed a 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
7-fold (86%) reduction. However, we observed an increase in absorbed dose of 38% when 
comparing the EOS standard-dose protocol with our CR system. 
Conclusions.The EOS imaging micro-dose option exposes patients to lower radiation doses than 
any currently available modality for full-spine examination. Expected reduction of dose was 
established for the adolescent phantom when comparing CR and standard-dose protocol. 
However, no reduction of effective dose with EOS standard-dose protocol compared to our 
reference CR system was observed in the pediatric phantom.  
Keywords: radiation dose, organ dose, effective dose, full-spine radiography, scoliosis, micro-
dose, low-dose, anthropomorphic phantoms, cancer risk, cumulative dose, slot-scanning system, 
EOS stereo-radiography, phantom dosimetry. 
Level of Evidence: N/A 
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Introduction 
Adequate radiological imaging is required for the assessment and treatment of spinal deformity.  
Patients are frequently exposed to numerous radiographs; during diagnosis and treatment, 
whether conservative or surgical, and follow-up. The higher the total absorbed radiation dose, the 
higher is the risk of developing radiation-induced cancer. The atom bomb survivor studies 1 
show a direct correlation between the total absorbed radiation dose and the risk of developing 
cancer. Especially children are at risk, since the stochastic damage caused by ionizing radiation 
often has a latency period of 1 or more decades before developing into cancer 2. A large cohort 
study 3 showed a 68% increase in mortality, with a standard mortality ratio of 1.68 from breast 
cancer amongst a cohort of 5573 scoliosis patients followed for more than 40 years after being 
diagnosed and exposed to frequent radiographic examinations. Furthermore, a recent study 
indicated an increased risk of endometrial cancer amongst scoliosis patients as well 4. To address 
this challenge, much effort has gone into optimizing radiologic equipment and finding 
alternatives to keep radiation dose as low as possible in order to decrease the risk of radiation-
induced cancer while maintaining adequate image quality; commonly referred to as the ALARA 
principle(as low as reasonable achievable) 5. 
The EOS low-dose imaging system (EOS imaging®, Paris, France) has been developed to 
produce high quality images at low radiation doses 6.  We have been using the EOS scanner for 
full-spine examinations at our institution, since the fall of 2014. The EOS scanner uses a bi-
planar slot-scanning technology, which has been described in detail elsewhere7–10 . The original 
version of the system had a standard low-dose protocol. Lately, a micro-dose protocol with even 
lower dose imaging has become an option. EOS standard-dose setting has mainly been evaluated 
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with regards to skin entrance dose7,9,11; however, only a few studies have evaluated organ dose 
and full-body absorbed dose (effective dose)10–12. 
The micro-dose protocol has so far mainly been evaluated in terms of image quality although an 
up to 45-fold reduction of absorbed radiation dose compared to CR has been stated 13; a recent 
study reported effective dose estimates, based on the Monte Carlo dose-simulation program 
(PCXMC) 14 using a mathematical phantom.  The micro-dose protocol has previously been 
reported to provide the clinician with  images comparable to CR13,15. 
The dual aim of our study was, first to report the first-ever organ dose and effective dose 
measurements in anthropomorphic phantoms using the EOS micro-dose protocol; second  to 
compare our results to measurements in the EOS standard-dose protocol and CR.   
Materials and methods 
Phantom exposure  
Two clinically validated anthropomorphic CIRS-ATOM®  phantoms(-Computerized Imaging 
Reference System, Inc. Norfolk, VA., USA) 16, a female adult (representing an adolescent) and a 
pediatric, were used. ATOM dosimetry phantoms have been designed to explore organ dose and 
effective dose, they consist of tissue equivalent epoxy resins and hold dosimeter locations 
specific to 21 inner organs. 
Each phantom was positioned in the upright position within the EOS® scanner (Fig. 1). Full 
spine biplane radiological examinations were performed in two positions: anterior-posterior-
lateral (APL) and posterior-anterior-lateral (PAL). Left lateral side of the phantom facing x-ray 
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source in the APL position and right lateral side in PAL. Vertical collimation with a laser 
positioning system was done in order to ascertain identical scan fields.   
The micro-dose protocol shown in Table 1 differs from the standard-dose protocol by featuring 
increased cobber (Cu) filtration, decreased x-ray tube voltage (kV), and optimized image 
processing. 
As previously described by Damet et al10, 20 consecutive scans were performed in each position 
in order to accumulate sufficient dose for measurements of the absorbed dose. The doses 
measured for each position were normalized into single examinations, and are listed as such in 
tables and figures. Measurements were done similarly for full-spine PA and AP, and 
subsequently, lateral (LAT) positions in CR (Siemens Ysio Max, Malvern, PA., USA), with CR 
long cassette wall stand, imaging parameters used are shown in Table 2. For CR LAT exposures, 
the right lateral side of the phantoms faced the x-ray-source according to in-house scoliosis 
protocol.  
Dosimetry 
TLD dosimeters (MCP-N, Krakow, Poland) were used for dosimetry. MCP-N dosimeters have a 
threshold of detecting radiation that is 200 times lower than more commonly used TLD-100 
dosimeters. 
Each TLD was placed within the phantoms at organ-specific positions and table-listed depths; 
eight dosimeters were placed on skin surfaces. All available internal dosimeter locations were 
used. The total of measuring points was in the range 184 (pediatric phantom) to 298(adolescent 
phantom).  For calibration and dose readings, Rados IR-2000 irradiator and the Rados RE-2000 
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reader (RadPro International GmbH, Wermelskirchen, Germany) were used. Mean organ doses 
were measured, and effective doses were calculated as described in previous studies10,17. 
Effective dose  E ,  ∑ , represents the full-body stochastic health risk, which is the 
probability of cancer induction and genetic effects, from any partial radiation of the body. 
Effective dose is measured in milisieverts (mSv), and according to the International Commission 
on Radiological Protection( ICRP) publication 103 5, calculated by summing the equivalent dose 
of each organ (   , which for x-ray radiation is equal to the average absorbed radiation dose for 
each organ, multiplied by a tissue-specific weighting(  factor.  
Statistical methods  
Radiation dose was visualized by log10-transforming measurement data in order to compare 
standard-dose and micro-dose. Furthermore, this reduced variability of data observed due to the 
underlying proportionality in mean and variance. We used a negative binominal regression 
method in order to statistically model data. Data observation was used to identify the expected 
additive structure in mean for the radiation dose, i.e. the only interaction terms were between 
organs and the position of the phantom relative to the source (APL/PAL). From the statistical 
model, expected tissue/organ levels were estimated for the two directions (APL/PAL) with an 
additive term due to different dose protocols. Based on the estimated model parameters and 
associated standard errors, the ratio of absorbed dose was compared between CR, micro-dose 
and standard-dose. The estimated absorbed dose was evaluated using the estimated model 
parameters and tissue-factors from predetermined positions. The associated 95% confidence 
intervals were evaluated using parametric bootstrap similar to the mean estimate 18. This 
parametric bootstrap was used in order to assess how the uncertainty in parameter estimates was 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.




Adolescent phantom. All 290 internal TLD positions were available for TLD placement; so were 
8 dosimeters placed on skin surfaces around the phantom. A few dosimeters were lost during 
dosimetry; 1-6 out of a total of 298 equal to 0.3-2% of the dosimeters used for calculating 
effective dose.  
Pediatric phantom. A total of 176 out of 180 internal TLD positions were available for 
placement of dosimeters. Four positions lost were due to image quality insert cylinders. An 
additional 8 dosimeters were placed on the surface of the phantoms for skin dose measurements. 
In most positions and exposure-protocols a few dosimeters were lost during read-outs; either 
because they were broken or had fallen out. The number of lost dosimeters ranged from 0-2 per 
exposure-position, equal to 0-1% of the dosimeters used for calculating effective doses. 
Dosimeter readings from the three positions representing prostate and testes have not been 
included in the results; the phantoms represented females. 
Effective doses  
Figure 2 provides an overview of effective doses for both phantoms and exposure positions, 
including CR. 
Adolescent phantom. We observed a 17-fold reduction (94%) of absorbed dose in micro-dose 
settings compared to measured dose absorbed with CR. Effective dose for PAL full spine, bi-
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planar, radiographic examination with the micro-dose protocol was 29µSv (27-31); the 
corresponding dose for CR PA-LAT was 491 µSv (456-531).A 6-fold reduction (83%) of 
effective dose was observed when comparing micro-dose with standard dose protocol. A 2.8-fold 
(64%) reduction of effective dose reduction was observed when comparing standard dose 
protocol with our CR system in PA-LAT.  
Pediatric phantom. Effective dose for PAL full spine, bi-planar radiographic examination with 
the micro-dose protocol was 22 µSv (20-23); the corresponding dose for CR PA-LAT was 114 
µSv (104-127); this is equivalent to a 5-fold reduction, (81%) of absorbed dose. A 7-fold 
reduction (86%) of effective dose was observed when comparing micro-dose with standard-dose 
protocol. However, there was an increase in absorbed dose of 38% when the EOS standard dose 
settings were compared with our CR system in PA-LAT. 
Organ doses 
Figures 3-6 demonstrate organ doses with micro-dose and standard-dose protocols for both 
phantoms, and show PAL/APL relations. For most organs, doses were lower in PAL than in 
APL. Effective doses in PAL compared with APL were reduced by an average of 21% (20-22%) 
for the phantoms in both standard and micro-dose protocols. The adolescent mean organ dose to 
the breasts was reduced by 29% in PAL; this reduction was solely on the  left breast where dose 
was reduced from 403μSv to 73µSv, a 5.5-fold reduction, whereas the right breast dose was 
increased from 216 µSv to 287 µSv, a 33% increase in dose. 
Discussion 
To the best of our knowledge, the present study reports the first, anthropomorphic phantom 
based, measurements of effective dose and organ dose using the EOS micro-dose protocol. We 
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showed a significant reduction of absorbed doses using the micro-dose setting compared with a 
conventional system and to EOS standard-dose settings as summarized in Figure 2. We 
confirmed the manufacturer’s claim that the micro-dose scan delivers radiation equal to less than 
1 week of natural background radiation; viz. the  mean weekly exposure  is 46 µSv19. This 
finding corroborates that radiographic full-spine examinations can be performed without 
exposing the patient to more than very low amounts of ionizing radiation.  
By presenting organ dose measurements in a micro-dose protocol and calculating the effective 
dose, we contribute to the ongoing evaluation of the risk of tissue detriment and death from 
radiation-induced cancer. With an average world-wide annual effective dose of 2.4 mSv (range1-
10) per capita19 from natural background exposure, a full-spine examination with micro-dose 
protocol and an effective dose of 22-37 µSv represents a very low dose. Two annual full-spine 
examinations with micro-dose protocol for 25 consecutive years would yield an accumulated 
effective dose below 2mSv, which is equivalent to less than 1 year of natural background 
exposure. Hence, the EOS micro-dose option offers full-spine imaging at an almost negligent 
radiation level.  A recent study 13 reports a 45-fold dose reduction with the micro-dose protocol 
compared with CR. This is, in fact, true if one was to compare to the dose delivered in 
conventional scoliosis full-spine examinations  where  radiation doses have been reported to 
reach around 3.5 mSv13,20. As shown by our study, the CR dose with modern equipment used for 
AP-LAT spine imaging reached 0.545 mSv in the adolescent phantom. Damet et al10 found a 
comparable figure of 0.450 mSv for full-spine AP-LAT full-spine. Compared with our CR 
reference for PA-LAT full-spine doses, the micro-dose protocol offers a 17-fold reduction, which 
is still a marked reduction, but not in the means of 45-fold reduction. The radiation doses from 
modern systems have been much reduced [3, 21], and it seems that some reference guidelines for 
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full-spine effective doses need to be updated or reconsidered as far as the description of the dose 
reduction afforded by new systems is concerned.  
Interestingly, in the pediatric phantom, our standard dose protocol showed no dose reduction 
compared with our reference CR. The child CR measurements were repeated and yielded same 
results. However, the PA-LAT CR dose of 114 µSv (104-127), for the pediatric phantom was not 
far from the 150 µSv for 4-7 year-olds, reported by Gialousis et al 21. Some of the explanation 
for the low dose for the small-child CR is likely attributable to conventional imaging 
optimization. Furthermore, we used a reduced-dose scoliosis protocol with right lateral exposure. 
Radiation exposure of the lees radiation-sensitive right lateral side, has been reported to reduce 
lateral effective dose by up to 28% for children 22. 
For the adolescent phantom we observed an effective dose reduction with EOS standard dose 
compared with CR, which is consistent with previous reports 10,11. Our EOS standard-dose 
results for both phantoms are consistent with most reports10–12. Table 3 shows previously 
reported doses compared with the doses of the present study. Hui et al 14 reported an effective 
dose of 2.6 µSv for AP micro-dose projection, much lower than doses reported by any other 
study. We were surprised by this very low measure and have redone the calculations based on 
reported values. We found an effective dose of 3.1 µSv if we included the inherent aluminum 
filter of the EOS scanner in dose calculations, DAP values were used. If instead calculating 
effective dose from reported entrance skin dose, the effective dose was 5.2 μSv. The calculated 
values are closer to previously reported values but still very low. The exact reason is not known. 
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Organ doses to most organs were lower in PAL than in APL. Previous studies have documented 
that obtaining radiographs in the PA position decreases the amount of absorbed dose in most 
radiosensitive organs, and thus the effective dose [12, 22]. By measuring organ dose in both APL 
and PAL we were able to illustrate the dose divergence in the two positions for the EOS. The 
mean dose reduction in PAL versus PAL was 21%.  A 29% mean dose reduction to the breasts 
was observed in the adolescent phantom. This is consistent with findings of  Luo et al11, when 
including lateral dose. The reported 8-fold reduction did not include lateral dose11. The EOS 
PAL position should be favored as a means of reducing the previously reported elevated risk of 
breast cancer.  
Historically, different methods have been applied for assessing organ dose and effective dose in 
the EOS scanner. Initially skin-entrance dose was described in comparisons of TLD 
measurements on skin surfaces with EOS and CR, and to calculate effective dose with the 
PCXMC method24. Clavel et al 12 used GATE organ volume simulation with PCXMC to 
compare with TLD dose measurements.  Damet et al10 reported  organ dose and effective dose 
for the EOS standard protocol, based on measurements in anthropomorphic phantoms. The 
anthropomorphic phantoms provided us with a model closely mimicking the in vivo situation in 
terms of the anatomical placement of organs and tissue-equivalent materials. The setting allowed 
us to calculate patient organ doses and effective doses after direct exposure to dosimeters.   
A limitation of the method used, is the fact that measurements were based on 20 consecutive 
scans in each position and normalized to one scan, instead of making a number of individual 
scans and measurements. Damet et al10 used only a fraction of available dosimeter placements 
(<25%) within the phantoms. Using only some of the predetermined dosimeter locations allows 
for considerable variations of dose measurements. For instance, four out of 28 TLD locations 
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were used in the liver for the adolescent phantom allowing for more than 20.000 possible 
combinations! 
We chose to strengthen our study, by using all internal dosimeter locations. This allowed us to 
evaluate more precisely the mean absorbed dose within each organ. Furthermore, to address the 
uncertainties inherent in any studies within this area, we performed negative binomial regression 
analysis as described above.  
This model provided a more flexible framework for count data interpretation, than the Poisson 
regression, in the case of potential overdispersion, which was the case in this study. 
Even with new low-dose imaging we still have to keep focusing on ALARA, keeping the 
radiation dose as low as possible. The mean annual absorbed dose of ionizing radiation from 
medical causes is on the rise. Currently the annual absorbed dose is estimated at 1.2 mSv25. So 
far, no lower threshold for the amount of ionizing radiation  causing tissue damage, and 
potentially radiation-induced cancer has been established1. Still, we need to devote efforts to 
keeping the risk from radiation-induced cancer from full-spine examinations lower than 
previously  reported levels3,26; and we need to continuously work towards minimizing the total 
radiation dose to which we expose our patients. 
 
Acknowledgements: 
We acknowledge the valuable support of University College Nordjylland (Radiografskolen), 
Selma LagerløfsVej 2, 9220 Aalborg Ø, Denmark, providing access to TLD irradiator and dose 
reader along with technical support. 
 
  
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
References 
 
1.  Ozasa K, Shimizu Y, Suyama A, et al. Studies of the Mortality of Atomic Bomb Survivors 
, Report 14 , 1950 – 2003 : An Overview of Cancer and Noncancer Diseases. Radiat Res 
2012;243:229–43. 
2.  Pace N, Ricci L, Negrini S. A comparison approach to explain risks related to X-ray 
imaging for scoliosis, 2012 SOSORT award winner. Scoliosis 2013;8:11. 
3.  Doody MM, Ronckers CM, Land CE, et al. Cancer mortality among women frequently 
exposed to radiographic examinations for spinal disorders. Radiat Res 2010;174:83–90. 
4.  A. S, S.B. C, K.E. J, et al. Incidence of cancer and infertility, in patients treated for 
adolescent idiopathic scoliosis 25 years prior. Eur Spine J 2015;24:S740. 
5.  ICRP Publication 103 The 2007 Recommendations of the International Commission on 
Radiological Protection. 
6.  Melhem E, Assi A, El Rachkidi R, et al. EOS(®) biplanar X-ray imaging: concept, 
developments, benefits, and limitations. J Child Orthop 2016;10:1–14. 
7.  Deschênes S, Charron G, Beaudoin G, et al. Diagnostic imaging of spinal deformities: 
reducing patients radiation dose with a new slot-scanning X-ray imager. Spine (Phila Pa 
1976) 2010;35:989–94. 
8.  Yvert M, Diallo A, Bessou P, et al. Radiography of scoliosis: Comparative dose levels and 
image quality between a dynamic flat-panel detector and a slot-scanning device (EOS 
system). Diagn Interv Imaging. Epub ahead of print 2015. DOI: 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
10.1016/j.diii.2015.06.018. 
9.  Kalifa G, Charpak Y, Maccia C, et al. Evaluation of a new low-dose digital X-ray device: 
First dosimetric and clinical results in children. Pediatr Radiol 1998;28:557–61. 
10.  Damet J, Fournier P, Monnin P, et al. Occupational and patient exposure as well as image 
quality for full spine examinations with the EOS imaging system Occupational and patient 
exposure as well as image quality for full spine examinations with the EOS imaging 
system. Med Phys;63901. Epub ahead of print 2014. DOI: 10.1118/1.4873333. 
11.  Luo TD, Stans AA, Schueler BA, et al. Cumulative radiation exposure with EOS imaging 
compared with standard spine radiographs. Spine Deform 2015;3:144–50. 
12.  Clavel AH, Thevenard-Berger P, Verdun FR, et al. Organ radiation exposure with EOS: 
GATE simulations versus TLD measurements. 2016;9783:978352. 
13.  Ilharreborde B, Ferrero E, Alison M, et al. EOS microdose protocol for the radiological 
follow-up of adolescent idiopathic scoliosis. Eur Spine J 2016;25:526–31. 
14.  Hui SCN, Pialasse J-P, Wong JYH, et al. Radiation dose of digital radiography (DR) 
versus micro-dose x-ray (EOS) on patients with adolescent idiopathic scoliosis: 2016 
SOSORT- IRSSD “John Sevastic Award” Winner in Imaging Research. Scoliosis Spinal 
Disord 2016;11:46. 
15.  Newton PO, Khandwala Y, Bartley CE, et al. New EOS Imaging Protocol Allows a 
Substantial Reduction in Radiation Exposure for Scoliosis Patients. Spine Deform 
2016;4:138–44. 
16.  Body W, Organ D, Therapeutic D. ATOM Dosimetry Phantoms Size and Age Related 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Dose Calculations Features : 
17.  Fujii K, Akahane K, Miyazaki O, et al. Evaluation of organ doses in CT examinations 
with an infant anthropomorphic phantom. Radiat Prot Dosimetry 2011;147:151–5. 
18.  Haukoos JS, Lewis RJ. Advanced statistics: Bootstrapping confidence intervals for 
statistics with “difficult” distributions. Acad Emerg Med 2005;12:360–5. 
19.  UNSCEAR. SOURCES AND EFFECTS OF IONIZING RADIATION United Nations 
Scientific Committee on the Effects of Atomic Radiation. 2010. 
20.  Mogaadi M, Ben Omrane L, Hammou A. Effective dose for scoliosispatients undergoing 
full spine radiography. Radiat Prot Dosimetry 2012;149:297–303. 
21.  Gialousis G, Yiakoumakis EN, Makri TK, et al. Comparison of dose from radiological 
examination for scoliosis in children among two pediatric hospitals by Monte Carlo 
simulation. Heal Phys 2008;94:471–8. 
22.  Ben-Shlomo A, Bartal G, Mosseri M, et al. Effective dose reduction in spine radiographic 
imaging by choosing the less radiation-sensitive side of the body. Spine J 2015;16:558–
63. 
23.  Chaparian A, Kanani A, Baghbanian M. Reduction of radiation risks in patients 
undergoing some X-ray examinations by using optimal projections: A Monte Carlo 
program-based mathematical calculation. J Med Phys 2014;39:32–9. 
24.  Servomaa  a., Tapiovaara M. Organ Dose Calculation in Medical X Ray Examinations by 
the Program PCXMC. Radiat Prot Dosimetry 1998;80:213–9. 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
25.  Samara ET, Aroua A, Bochud FO, et al. Paper EXPOSURE OF THE SWISS 
POPULATION BY MEDICAL X-RAYS : 2008 REVIEW. 2012;263–70. 
26.  Doody MM, Lonstein JE, Stovall M, et al. Breast cancer mortality after diagnostic 





















































Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Figure 2.Effective doses for anthropomorphic phantoms with different imaging protocols. PAL 
(posterior-anterior + lateral exposure). APL (anterior-posterior + lateral exposure). CR 
(conventional digital radiology, scoliosis protocol), EOS st (EOS standard-dose protocol), EOS 
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Figure 3. Mean organ doses in APL and PAL with micro-dose protocol, for the adolescent 





Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Figure 4. Mean organ doses in APL and PAL with standard-dose protocol, for the adolescent 
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Figure 5. Mean organ doses in APL and PAL with micro-dose protocol, for the child phantom. 
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Figure 6. Mean organ doses in APL and PAL with standard-dose protocol, for the child 
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Standard-Dose Micro-Dose Standard-Dose Micro-dose 
Morphotype Small Small Medium Medium 
Scan Speed 4 3 4 4 
Anterior X-Ray 
Tube 
    
kV 83 60 90 65 
mA 200 80 250 80 
DAP1 (mG.cm2) 200 27 437 65 
Lateral X-Ray 
Tube 
    
kV 102 80 105 90 
mA 200 80 250 80 
DAP(mG.cm2) 
 
340 60 648 151 
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TABLE 2. CR Scoliosis Parameters (Siemens Ysio Max) 
CR scoliosis protocols1 Pediatric Phantom Female adolescent phantom 
Anterior exposure   
kV 85 96 
mAs 10 40 
DAP(mGycm2) 120 1510 
Lateral exposure2   
kV 90 102 
mAs 16 63 
DAP(mGycm2) 190 1470 
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Damet et al 
201410 
(Adult Phantom)* 
0.45 0.30 0.13 0.290 
Luo et al 201511 
(PCXMC, adult) 
0.33 0.35 0.17 0.240 
Present study 
(Adult Phantom)* 
0.31 0.37 0.09 0.220 
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